Faced with the challenge of falling success rates in drug development, clinical development teams must find new ways forward. Tessella and Berry Consultants believe that designing smarter clinical trials is part of the solution. We believe that better trial design can help: • Maximize the impact of your clinical trials on your drug development process. [...]
Yili Pritchett of Abbott was able to show real data from a trial we ran for them between 2007-2009. Read more.
Kevin Davies, Editor-in-Chief, Bio-IT and Tessella’s Dr Andrew Chadwick, Principle Consultant, Life Sciences and Health Care discuss Translational Medicine. Listen to this podcast and learn about: Effective, ethical approaches to trial design that harness incompletely validated predictive and prognostic biomarkers Ways to improve the value of image information and other rich data The tradeoffs to [...]
Quick ‘bench-to-bedside’ clinical trial would enroll 1,400 influenza patients to test corticosteroids and statins as potential treatments TORONTO, Ont., November 10, 2009 — An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. Read more ….
BOSTON, Nov. 2, 2009 (GLOBE NEWSWIRE) — AG Mednet, the world’s largest diagnostic imaging network, announced today that more than 2000 users around the world have been credentialed to access and use its electronic diagnostic image submission platform…read more
Adaptive Trial Design Forum, February 26 2009, Windsor, UK Tom Parke, Head of Clinical Trials Solutions at Tessella is co-hosting along with Scott Berry of Berry Consultants; the first Adaptive Trial Design Symposium, held February 26 2009, Beaumont Estate, Old Windsor, UK. Sponsored by Cmed, this exciting meeting will be a showcase for Adaptive Trials, [...]
